Regulatory Update – April 3, 2023 Post author:PacConAdmin Post published:March 31, 2023 Post category:Drug Industry Daily Source: Drug Industry Daily You Might Also Like PhRMA, Lilly Urge HHS to Create New Safe Harbors for Value-Based Payments & PBM Fees March 10, 2017 EMA Recommends Withdrawal of Obesity Drugs Containing Amfepramone June 13, 2022 Gottlieb Outlines FDA Plans for Compounding Enforcement to Lawmakers January 30, 2018
